Strategies to Improve Outcomes in Patients with Asthma

This CME Program will provide physicians with imperative information about the rationale of asthma control for each stage of disease. Expert panel will discuss biomarkers of disease activity, new biologics and the asthma and COPD overlap syndrome among other relevant topics. Physicians will also be exposed to different disease monitoring tools as well as recent clinical trial data to ensure appropriate and individualized treatment plans can be implemented in their practice. With the information provided, learners will be able to better treat and manage their asthma patients and improve overall quality of life in those individuals through both short-term gains and long-term successes.

Target Audience

Allergists/Immunologists, pulmonologists, primary care physicians, and other healthcare clinicians responsible for the care of patients with asthma 

Educational Objectives

Upon completion of this activity, participants will be able to:

  1. Examine the pathology of asthma, and discuss the characteristics of pediatric and adult-onset asthma to ensure differential diagnosis
  2. Review the rationale of asthma control of each stage of disease, in addition to disease monitoring tools and recent clinical trial data to ensure appropriate treatment selection
  3. Implement patient education and communication tactics in individualized treatment plans to improve patient adherence, self-management, and overall quality of life in asthma patients

Faculty

Reynold A. Panettieri, Jr, MD
Robert L. Mayock and David A. Cooper Professor of Medicine
Director, Airways Biology Initiative
Adjunct Professor, Wistar Institute
Deputy Director, Center of Excellence in Environmental Toxicology
University of Pennsylvania Medical Center
Philadelphia, Pennsylvania

Bradley Chipps, MD
Medical Director, Cystic Fibrosis Center
Capital Allergy & Respiratory Disease Center
Associate Medical Director, Sleep Laboratory of Sutter Community Hospitals
Sacramento, California

 

Jonathan Corren, MD
Medicine, Allergy & Immunology Specialist
Allergy Medical Clinic
Associate Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

 
 

Disclosure of Conflicts of Interest

It is the policy of the Elsevier Office of Continuing Medical Education that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity. 

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty                                  

Relationship Identified With:

Reynold A. Panettieri, Jr, MD

Consultant/Advisor: AstraZeneca; Johnson and Johnson Research Institute for Fragrance Materials; Teva Pharmaceuticals Industries Ltd.

Grant/Research Support: AstraZeneca; Gilead Sciences, Inc.; Johnson and Johnson; Merck & Co., Inc.; Research Institute for Fragrance Materials; Roche; Sanofi-aventis U.S. LLC

Bradley Chipps, MD

Consultant/Advisor: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc.; Meda Pharmaceuticals Inc.; Merck & Co., Inc; Novartis

Speaker's Bureau: AstraZeneca, Boehringer Ingelheim, Genentech, Inc.; Meda Pharmaceuticals Inc.; Merck & Co., Inc, Novartis

Jonathan Corren, MD

Consultant/Advisor: Genentech, Inc:

Grant/Research Support: Genentech, Inc.; MedImmune; Sanofi- Aventis U.S. LLC.; Teva Pharmaceuticals Industries Ltd.

Speaker's Bureau: Genentech, Inc.; MedImmune; Sanofi- Aventis U.S. LLC.; Teva Pharmaceuticals Industries Ltd.

Non-faculty: Sandy Breslow; Alison Kemp; Timothy Hayes, MD, PhD; Kristen Scollon; Emma Gilmartin; Nicole Brestowski and Bernard M. Abrams, MD hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. 

Financial Support

This activity has been supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Provider Information

Co-provided by the Elsevier Office of Continuing Medical Education and AcademicCME.

CME Credit (Physician)

The Elsevier Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Elsevier Office of Continuing Medical Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Inquiries/Special Needs

For all CME inquiries or special needs, please contact elsevierCME@elsevier.com.

Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Elsevier Office of Continuing Medical Education, AcademicCME, and Boehringer Ingelheim Pharmaceuticals, Inc. do not recommend the use of any agent outside of the labeled indications.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Non-physician
Course opens: 
03/10/2016
Course expires: 
03/09/2017
Rating: 
5

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Non-physician
Please login or register to take this course.